Skip to main content
Caplight Logo









Abiochem Biotechnology

Abiochem Biotechnology

Private
ShanghaiHealthcare & Life Scienceshttps://abiochem.com/

Last Round

Strategic

Jul 24, 2025

Total Funding Raised

$124.2M

Company Overview

Abiochem Biotechnology is a synthetic biology company that develops and manufactures chemical and biological products for the pharmaceutical, agricultural, and food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Drug Discovery, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

synthetic biologybiomanufacturingsynbioCDMOcontract manufacturingenzyme engineeringactive pharmaceutical ingredientsAPIindustrial fermentationcell factorybioprocess engineeringCROcontract researchgreen chemistrybio-based ingredients

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abiochem Biotechnology Comparables

Compare Abiochem Biotechnology with similar companies based on industry and business-model similarity.

Abiochem Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bota Biosciences
81%
上海依诺基科生物技术有限公司
77%
Tidetron Bioworks
77%

Abiochem Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 24, 2025
Series CApr 30, 2021
Series BNov 30, 2020
Series AApr 3, 2019
AngelJun 28, 2018

Abiochem Biotechnology Investors

Notable investors and investment history

Abiochem Biotechnology investors
InvestorRounds
TemasekSeries C
招银国际金融有限公司Series C
Addor CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2025

    $63M raised in strategic round.

  • Apr 30, 2021

    $46.3M round led by Temasek

Abiochem Biotechnology Filings

Explore SEC and related filing metadata, where available.

Abiochem Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Abiochem Biotechnology's valuation, stock price, and market status.

Is Abiochem Biotechnology a public or private company?

Abiochem Biotechnology is a private company.

What is the current stock price of Abiochem Biotechnology?

Abiochem Biotechnology is a private company with no public stock price. Caplight tracks Abiochem Biotechnology's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Abiochem Biotechnology worth (valuation)?

Valuation information for Abiochem Biotechnology is not publicly available.

Can I buy Abiochem Biotechnology stock?

Abiochem Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Abiochem Biotechnology's last funding round?

Abiochem Biotechnology's most recent funding round was Strategic on July 24, 2025.

Who are the main investors in Abiochem Biotechnology?

Key investors in Abiochem Biotechnology include Temasek.

Will Abiochem Biotechnology IPO soon?

No public IPO plans have been announced for Abiochem Biotechnology.

How can I track Abiochem Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Abiochem Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Year Founded2015
Last FundingJul 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?